GSK's Curbs On Parallel Trading May Be Illegal: Court
A GlaxoSmithKline PLC subsidiary's practice of selling three drugs in Greece on a quota system in order to combat parallel trading may constitute a violation of competition laws, Europe's highest court...To view the full article, register now.
Already a subscriber? Click here to view full article